HBM4003 Combine With Toripalimab in Patients With Advanced NEN and Other Solid Tumors Study
Clinical trial NCT05167071 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05167071
- Sponsor
- Harbour BioMed (Guangzhou) Co. Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-28
- Primary completion
- 2025-09-30
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.